Cargando…
An Engineered Arginase FC Protein Inhibits Tumor Growth In Vitro and In Vivo
Arginine is a semiessential amino acid required for the growth of melanoma and hepatocellular carcinoma, and the enzymatic removal of arginine by pegylated arginine deiminase (ADI) or arginase is being tested clinically. Here, we report a genetically engineered arginase FC fusion protein exhibiting...
Autores principales: | Li, Lihua, Wang, Yan, Chen, Jun, Cheng, Bi, Hu, Jiehua, Zhou, Yuehua, Gao, Xin, Gao, Liucun, Mei, Xifan, Sun, Meiyan, Zhang, Zhuomei, Song, Haifeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3662114/ https://www.ncbi.nlm.nih.gov/pubmed/23737831 http://dx.doi.org/10.1155/2013/423129 |
Ejemplares similares
-
Isoalantolactone Inhibits UM-SCC-10A Cell Growth via Cell Cycle Arrest and Apoptosis Induction
por: Wu, Minjun, et al.
Publicado: (2013) -
Synthetic DNA Delivery of an Engineered Arginase Enzyme Can Modulate Specific Immunity In Vivo
por: Khoshnejad, Makan, et al.
Publicado: (2020) -
Topical arginase inhibition decreases growth of cutaneous squamous cell carcinoma
por: Mittal, Amit, et al.
Publicado: (2021) -
The Effect of Arginase on the Retardation of Tumour Growth
por: Bach, S. J., et al.
Publicado: (1965) -
HGG-27. ANTI-CANCER POTENTIAL OF ARGINASE FOR HIGH-GRADE GLIOMA IN VITRO & IN-VIVO
por: Fung, M K L, et al.
Publicado: (2020)